Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2026-01-02 @ 3:01 AM
Study NCT ID:
NCT03898193
Status:
COMPLETED
Last Update Posted:
2019-06-06
First Post:
2019-03-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study of Montelukast, 5 mg Chewable Tablets (Pharmtechnology LLC, Belarus), and Singulair®, 5 mg Chewable Tablets (Merck Sharp & Dohme B.V., the Netherlands), in Healthy Volunteers Under Fasting Conditions
Sponsor:
Pharmtechnology LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-23
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04-08
Completion Date Type:
ACTUAL
First Submit Date:
2019-03-29
First Submit QC Date:
None
Study First Post Date:
2019-04-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-06-05
Last Update Post Date:
2019-06-06
Last Update Post Date Type:
ACTUAL